Immunology News and Research

Latest Immunology News and Research

SAGE partners with The Katie Piper Foundation to launch journal Scars, Burns & Healing

SAGE partners with The Katie Piper Foundation to launch journal Scars, Burns & Healing

Argos Therapeutics begins AGS-003 clinical trial in patients with metastatic renal cell carcinoma

Argos Therapeutics begins AGS-003 clinical trial in patients with metastatic renal cell carcinoma

Researchers apply new approach to make improved nasal spray flu vaccine

Researchers apply new approach to make improved nasal spray flu vaccine

Researchers create new cell screening method for immunotherapy cancer treatments

Researchers create new cell screening method for immunotherapy cancer treatments

Roche establishes strategic alliance with Diagnostic Laboratory Services

Roche establishes strategic alliance with Diagnostic Laboratory Services

CRI to honor three scientists for contributions to immunology and cancer immunotherapy research

CRI to honor three scientists for contributions to immunology and cancer immunotherapy research

CRI announces winners of 2015 Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research

CRI announces winners of 2015 Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research

GenVec reports net loss of $1.9 million for second quarter 2015

GenVec reports net loss of $1.9 million for second quarter 2015

Experts discuss ways to encourage appropriate use of epinephrine for all severe allergic reactions

Experts discuss ways to encourage appropriate use of epinephrine for all severe allergic reactions

Researcher reveals link between inflammatory response of neutrophils and spread of oral cancer

Researcher reveals link between inflammatory response of neutrophils and spread of oral cancer

Study uncovers role of intra-abdominal fat cells in development and progression of IBD

Study uncovers role of intra-abdominal fat cells in development and progression of IBD

CRI commits $29.3 million in new funds to accelerate development of cancer immunotherapies

CRI commits $29.3 million in new funds to accelerate development of cancer immunotherapies

Top cancer research organizations to sponsor International Cancer Immunotherapy Conference in New York

Top cancer research organizations to sponsor International Cancer Immunotherapy Conference in New York

Study demonstrates significance of EMT as potential therapeutic target for reversing kidney disease

Study demonstrates significance of EMT as potential therapeutic target for reversing kidney disease

BGI to hold 10th International Conference on Genomics in October

BGI to hold 10th International Conference on Genomics in October

IDIBELL licenses a tool to Oxford Immunotec to improve efficiency of kidney transplants, prevent graft rejection

IDIBELL licenses a tool to Oxford Immunotec to improve efficiency of kidney transplants, prevent graft rejection

Researchers uncover new mechanism that p53 protein uses to trigger cell death

Researchers uncover new mechanism that p53 protein uses to trigger cell death

Researchers uncover master regulators that govern the fate of TFH cells

Researchers uncover master regulators that govern the fate of TFH cells

Roche submits cobas EGFR v2 test PMA to FDA as companion diagnostic test for AZD9291

Roche submits cobas EGFR v2 test PMA to FDA as companion diagnostic test for AZD9291

UC San Diego Health signs affiliation agreement with La Jolla Institute for Allergy and Immunology

UC San Diego Health signs affiliation agreement with La Jolla Institute for Allergy and Immunology

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.